Skip to main content
SpringerLink
Log in

Intrathecal Analgesia in Cancer Pain

  • Chapter
  • First Online:
Fundamentals of Cancer Pain Management

Part of the book series: Cancer Treatment and Research ((CTAR,volume 182))

Abstract

The number of new cancer cases has been increasing globally over the last several decades.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith TJ et al (2002) Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20(19):4040–4049

    Article  CAS  Google Scholar 

  2. Hayek SM et al (2011) Intrathecal therapy for cancer and non-cancer pain. Pain Phys 14(3):219–248

    Article  Google Scholar 

  3. Basbaum AI et al (2009) Cellular and molecular mechanisms of pain. Cell 139(2):267–284

    Article  CAS  Google Scholar 

  4. Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 124(1):53–67

    Google Scholar 

  5. Miljanich G, Rauck R, Saulino M (2013) Spinal mechanisms of pain and analgesia. Pain Pract 13(2):114–130

    Article  Google Scholar 

  6. Buvanendran A, Diwan SADT (2012) In: Intrathecal drug delivery for pain and spasticity. Philadelphia

    Google Scholar 

  7. Bernards CM (2002) Understanding the physiology and pharmacology of epidural and intrathecal opioids. Best Pract Res Clin Anaesthesiol 16(4):489–505

    Article  CAS  Google Scholar 

  8. Friese S et al (2004) The influence of pulse and respiration on spinal cerebrospinal fluid pulsation. Invest Radiol 39(2):120–130

    Article  Google Scholar 

  9. Bernards CM (2006) Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology 105(1):169–178

    Article  Google Scholar 

  10. Flack SH, Anderson CM, Bernards C (2011) Morphine distribution in the spinal cord after chronic infusion in pigs. Anesth Analg 112(2):460–464

    Article  CAS  Google Scholar 

  11. Ummenhofer WC et al (2000) Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil. Anesthesiology 92(3):739–753

    Article  CAS  Google Scholar 

  12. Deer TR et al (2017) The polyanalgesic consensus conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation 20(2):96–132

    Article  Google Scholar 

  13. Du Pen S, Du Pen A, Hillyer J (2006) Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study. Pain Med 7(1):10–15

    Article  Google Scholar 

  14. Deer TR et al (2012) Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 15(5):436–64; discussion 464–6

    Google Scholar 

  15. Deer TR et al (2012) Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses). Neuromodulation 15(5):483–95; discussion 496

    Google Scholar 

  16. Scholz A et al (1998) Complex blockade of TTX-resistant Na+ currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons. J Neurophysiol 79(4):1746–1754

    Article  CAS  Google Scholar 

  17. van Dongen RT, Crul BJ, van Egmond J (1999) Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 15(3):166–172

    Article  Google Scholar 

  18. Bianchi F, Ginggen A, Tardy Y (2008) Stability and compatibility of drug mixtures in an implantable infusion system. Anaesthesia 63(9):972–978

    Article  CAS  Google Scholar 

  19. Wille M (2004) Intrathecal use of ropivacaine: a review. Acta Anaesthesiol Belg 55(3):251–259

    CAS  PubMed  Google Scholar 

  20. Dupoiron D, Lefebvre-kuntz D, Brenet O, de Bourmont S, Grelon F, Dixmeria F , Buisset N, Monnin D (2011) Douleur chronique cancéreuse et analgésie intrathécale:expérience de trois centres de lutte contre le Cancer. Douleurs 12(3):140–146

    Google Scholar 

  21. Li H et al (2017) Successful treatment of refractory cancer pain with morphine and ropivacaine: a case report. Medicine (Baltimore) 96(22): e7052

    Google Scholar 

  22. Kristensen JD, Karlsten R, Gordh T (1996) Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg 82(3):636–640

    CAS  PubMed  Google Scholar 

  23. Schmidtko A et al (2010) Ziconotide for treatment of severe chronic pain. Lancet 375(9725):1569–1577

    Article  CAS  Google Scholar 

  24. Rauck RL et al (2006) A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 31(5):393–406

    Article  CAS  Google Scholar 

  25. Staats PS et al (2004) Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 291(1):63–70

    Article  CAS  Google Scholar 

  26. Wallace MS (2006) Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Rev Neurother 6(10):1423–1428

    Article  CAS  Google Scholar 

  27. Pope JE, Deer TR (2013) Ziconotide: a clinical update and pharmacologic review. Expert Opin Pharmacother 14(7):957–966

    Article  CAS  Google Scholar 

  28. Coombs DW et al (1986) Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. J Neurosurg 64(6):890–894

    Article  CAS  Google Scholar 

  29. Uhle EI et al (2000) Continuous intrathecal clonidine administration for the treatment of neuropathic pain. Stereotact Funct Neurosurg 75(4):167–175

    Article  CAS  Google Scholar 

  30. Ackerman LL, Follett KA, Rosenquist RW (2003) Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage 26(1):668–677

    Article  CAS  Google Scholar 

  31. Liu HJ et al (2014) Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain. J Palliat Med 17(7):837–840

    Article  Google Scholar 

  32. Lind G et al (2004) Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study. Eur J Pain 8(4):377–383

    Article  CAS  Google Scholar 

  33. Vranken JH et al (2006) Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine. Anesthesiology 105(4):813–818

    Article  CAS  Google Scholar 

  34. Rauck R et al (2013) Intrathecal gabapentin to treat chronic intractable noncancer pain. Anesthesiology 119(3):675–686

    Article  Google Scholar 

  35. Coffey RJ et al (2009) Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain. Anesthesiology 111(4):881–891

    Article  Google Scholar 

  36. Stearns L et al (2005) Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol 3(6):399–408

    CAS  PubMed  Google Scholar 

  37. Deer TR et al (2011) Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Phys 14(3):E283–312

    Article  Google Scholar 

  38. Carvajal G et al (2018) Intrathecal drug delivery systems for refractory pancreatic cancer pain: observational follow-up study over an 11-year period in a comprehensive cancer center. Anesth Analg 126(6):2038–2046

    Article  CAS  Google Scholar 

  39. Aprili D et al (2009) Serious complications associated with external intrathecal catheters used in cancer pain patients: a systematic review and meta-analysis. Anesthesiology 111(6):1346–1355

    Article  Google Scholar 

  40. Deer TR et al (2017) The polyanalgesic consensus conference (PACC): recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risks. Neuromodulation 20(2):155–176

    Article  Google Scholar 

  41. Hassenbusch SJ et al (2004) Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery–report of an expert panel. J Pain Symptom Manage 27(6):540–563

    Article  Google Scholar 

  42. Dupoiron D, Carvajal G (2018) High-resolution three-dimensional computed tomography reconstruction as first-line imaging modality to detect intrathecal catheter malfunction. Neuromodulation

    Google Scholar 

  43. Naumann C et al (1999) Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation 2(2):92–107

    Article  CAS  Google Scholar 

  44. Abs R et al (2000) Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 85(6):2215–2222

    Article  CAS  Google Scholar 

  45. Dupoiron D et al (2012) Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol. Pain Phys 15(5):395–403

    Article  Google Scholar 

  46. Alicino I et al (2012) Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice. Pain 153(1):245–249

    Article  CAS  Google Scholar 

  47. Dupoiron D et al (2014) In Vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps. Neuromodulation

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anesthesia and Pain Department, Institut de Cancérologie de L’Ouest, Rue Boquel, 49055, Angers, France

    Denis Dupoiron

Authors
  1. Denis Dupoiron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Denis Dupoiron .

Editor information

Editors and Affiliations

  1. Departments of Supportive Care Medicine and Anesthesiology, City of Hope National Medical Center, Duarte, CA, USA

    Andrew Leitner

  2. New York, NY, USA

    Christine Chang

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dupoiron, D. (2021). Intrathecal Analgesia in Cancer Pain. In: Leitner, A., Chang, C. (eds) Fundamentals of Cancer Pain Management. Cancer Treatment and Research, vol 182. Springer, Cham. https://doi.org/10.1007/978-3-030-81526-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81526-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81525-7

  • Online ISBN: 978-3-030-81526-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation